The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements
Open accessAbstract
BACKGROUND AND PURPOSE: Differentiating tumor growth from posttreatment radiation effect (PTRE) remains a common problem in neuro-oncology practice. To our knowledge, useful threshold relative cerebral blood volume (rCBV) values that accurately distinguish the 2 entities do not exist. Our prospective study uses image-guided neuronavigation during surgical resection of MR imaging lesions to correlate directly specimen histopathology with localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging (DSC) measurements and to establish accurate rCBV threshold values, which differentiate PTRE from tumor recurrence. MATERIALS AND METHODS: Preoperative 3T gradient-echo DSC and contrast-enhanced stereotactic T1-weighted images were obtained in patients with high-grade glioma (HGG) previously treated with multimodality therapy. Intraoperative neuronavigation documented the stereotactic location of multiple tissue specimens taken randomly from the periphery of enhancing MR imaging lesions. Coregistration of DSC and stereotactic images enabled calculation of localized rCBV within the previously recorded specimen locations. All tissue specimens were histopathologically categorized as tumor or PTRE and were correlated with corresponding rCBV values. All rCBV values were T1-weighted leakage-corrected with preload contrast-bolus administration and T2/T2*-weighted leakage-corrected with baseline subtraction integration. RESULTS: Forty tissue specimens were collected from 13 subjects. The PTRE group (n = 16) rCBV values ranged from 0.21 to 0.71, tumor (n = 24) values ranged from 0.55 to 4.64, and 8.3% of tumor rCBV values fell within the PTRE group range. A threshold value of 0.71 optimized differentiation of the histopathologic groups with a sensitivity of 91.7% and a specificity of 100%. CONCLUSIONS: rCBV measurements obtained by using DSC and the protocol we have described can differentiate HGG recurrence from PTRE with a high degree of accuracy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfusion imaging with NMR contrast agents
Rosen, B. R., Belliveau, J. W., Vevea, J. M., & Brady, T. J. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140211 · Cited by 1,151
Boxerman, J. L., Schmainda, K. M., & Weisskoff, R. M. (2006) · PubMed · Cited by 686
Kumar, A. J., Leeds, N. E., Fuller, G. N., Van Tassel, P., Maor, M. H., Sawaya, R. E., & Levin, V. A. (2000) · Radiology · doi:10.1148/radiology.217.2.r00nv36377 · Cited by 669
Di Chiro, G., Oldfield, E., Wright, D., De Michele, D., Katz, D., Patronas, N., Doppman, J., Larson, S., Ito, M., & Kufta, C. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.1.189 · Cited by 422
Terakawa, Y., Tsuyuguchi, N., Iwai, Y., Yamanaka, K., Higashiyama, S., Takami, T., & Ohata, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048082 · Cited by 419
Chen, W., Silverman, D. H. S., Delaloye, S., Czernin, J. G., Kamdar, N. V., Pope, W. B., Satyamurthy, N., Schiepers, C. W., & Cloughesy, T. F. (2006) · PubMed · Cited by 407
Dowling, C., Bollen, A. W., Noworolski, S. M., McDermott, M. W., Barbaro, N. M., Day, M. R., Henry, R. G., Chang, S. M., Dillon, W. P., Nelson, S. J., et al. (2001) · PubMed Central · Cited by 378
Paulson, E. S., & Schmainda, K. M. (2008) · Radiology · doi:10.1148/radiol.2492071659 · Cited by 327
Patronas, N. J., Di Chiro, G., Brooks, R. A., DeLaPaz, R. L., Kornblith, P. L., Smith, B. H., Rizzoli, H. V., Kessler, R. M., Manning, R. G., Channing, M., et al. (1982) · Radiology · doi:10.1148/radiology.144.4.6981123 · Cited by 298
Donahue, K. M., Krouwer, H. G. J., Rand, S. D., Pathak, A. P., Marszalkowski, C. S., Censky, S. C., & Prost, R. W. (2000) · Magnetic Resonance in Medicine · doi:10.1002/1522-2594(200006)43:6<845::aid-mrm10>3.0.co;2-j · Cited by 253
Stadlbauer, A., Ganslandt, O., Buslei, R., Hammen, T., Gruber, S., Moser, E., Buchfelder, M., Salomonowitz, E., & Nimsky, C. (2006) · Radiology · doi:10.1148/radiol.2403050937 · Cited by 200
Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
Kahn, D. J., Follett, K. A., Bushnell, D., Nathan, M. A., Piper, J., Madsen, M. T., & Kirchner, P. T. (1994) · American Journal of Roentgenology · doi:10.2214/ajr.163.6.7992747 · Cited by 158
Vascular morphology and angiogenesis in glial tumors
Plate, K. H., & Mennel, H. D. (1995) · Experimental and Toxicologic Pathology · doi:10.1016/s0940-2993(11)80292-7 · Cited by 131
The Role of Vascular Proliferation in the Growth of Brain Tumors
Brem, S. S. (1976) · Neurosurgery · doi:10.1093/neurosurgery/23.cn_suppl_1.440 · Cited by 123
Wesseling, P., van der Laak, J. A. W. M., de Leeuw, H., Ruiter, D. J., & Burger, P. C. (1994) · Journal of neurosurgery · doi:10.3171/jns.1994.81.6.0902 · Cited by 113
Fuß, M., Wenz, F. K., Scholdei, R., Essig, M., Debus, J., Knopp, M. V., & Wannenmacher, M. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00590-3 · Cited by 106
Differentiation of recurrent astrocytoma from radiation necrosis: a pilot study with 13N-NH3 PET
Zhang, X., & Weian, C. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9286-y · Cited by 51
Gijtenbeek, J. M. M., Wesseling, P., Maass, C., Burgers, L., & van der Laak, J. A. W. M. (2005) · Angiogenesis · doi:10.1007/s10456-005-9019-4 · Cited by 35
Cited by
Barajas, R. F., Chang, J. S., Segal, M. R., Parsa, A. T., McDermott, M. W., Berger, M. S., & Cha, S. (2009) · Radiology · doi:10.1148/radiol.2532090007 · Cited by 407
Pseudoprogression and pseudoresponse in the treatment of gliomas
Brandsma, D., & van den Bent, M. J. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328332363e · Cited by 378
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Dhermain, F. G., Hau, P., Lanfermann, H., Jacobs, A. H., & van den Bent, M. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70181-2 · Cited by 368
Perfusion MRI: The Five Most Frequently Asked Clinical Questions
Essig, M., Nguyen, T. B., Shiroishi, M. S., Saake, M., Provenzale, J. M., Enterline, D. S., Anzalone, N., Dörfler, A., Rovira, À., Wintermark, M., et al. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9544 · Cited by 344
Advances in neuro-oncology imaging
Langen, K.-J., Galldiks, N., Hattingen, E., & Shah, N. J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.44 · Cited by 339
Metadata
- Authors
- Hu, L. S., Baxter, L. C., Smith, K. A., Feuerstein, B. G., Karis, J. P., Eschbacher, J. M., Coons, S. W., Nakaji, P., Yeh, R. F., Debbins, J., & Heiserman, J. E.
- Venue
- American Journal of Neuroradiology
- Published
- 2008-12-04
- Volume
- 30
- Issue
- 3
- Pages
- 552-558
- ISSN
- 0195-6108 (ISSN-L)
- 1936-959X
- OpenAlex
- W2102099315
- Cited by
- 396
- References
- 18
- FWCI
- 7.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.